News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
393,656 Results
Type
Article (46885)
Company Profile (79)
Press Release (346692)
Multimedia
Podcasts (20)
Webinars (10)
Section
Business (112194)
Career Advice (1299)
Deals (15336)
Drug Delivery (43)
Drug Development (48420)
Employer Resources (92)
FDA (7469)
Job Trends (8706)
News (182965)
Policy (14068)
Tag
Academia (2603)
Academic (1)
Accelerated approval (4)
Adcomms (6)
Allergies (46)
Alliances (32678)
ALS (64)
Alzheimer's disease (1136)
Antibody-drug conjugate (ADC) (77)
Approvals (7512)
Artificial intelligence (174)
Autoimmune disease (11)
Automation (7)
Bankruptcy (87)
Best Places to Work (6888)
BIOSECURE Act (10)
Biosimilars (27)
Biotechnology (52)
Bladder cancer (41)
Brain cancer (22)
Breast cancer (172)
Cancer (1561)
Cardiovascular disease (90)
Career advice (1085)
Career pathing (21)
CAR-T (105)
Cell therapy (270)
Cervical cancer (10)
Clinical research (37839)
Collaboration (628)
Compensation (72)
Complete response letters (6)
COVID-19 (1852)
CRISPR (30)
C-suite (127)
Cystic fibrosis (64)
Data (1537)
Decentralized trials (2)
Denatured (8)
Depression (29)
Diabetes (142)
Diagnostics (3734)
Digital health (10)
Diversity (4)
Diversity, equity & inclusion (24)
Drug discovery (94)
Drug pricing (47)
Drug shortages (6)
Duchenne muscular dystrophy (48)
Earnings (41876)
Editorial (20)
Employer branding (14)
Employer resources (80)
Events (48027)
Executive appointments (423)
FDA (8151)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (469)
Gene editing (61)
Generative AI (15)
Gene therapy (194)
GLP-1 (392)
Government (2217)
Grass and pollen (2)
Guidances (43)
Healthcare (10572)
Huntington's disease (10)
IgA nephropathy (7)
Immunology and inflammation (53)
Indications (19)
Infectious disease (1939)
Inflammatory bowel disease (92)
Inflation Reduction Act (4)
Influenza (39)
Intellectual property (58)
Interviews (261)
IPO (7404)
IRA (26)
Job creations (2116)
Job search strategy (937)
Kidney cancer (6)
Labor market (23)
Layoffs (245)
Leadership (8)
Legal (2402)
Liver cancer (35)
Lung cancer (218)
Lymphoma (111)
Machine learning (5)
Management (28)
Manufacturing (165)
MASH (48)
Medical device (5667)
Medtech (5669)
Mergers & acquisitions (8253)
Metabolic disorders (340)
Multiple sclerosis (52)
NASH (11)
Neurodegenerative disease (53)
Neuropsychiatric disorders (10)
Neuroscience (1492)
NextGen: Class of 2025 (3255)
Non-profit (3562)
Now hiring (24)
Obesity (149)
Opinion (138)
Ovarian cancer (60)
Pain (42)
Pancreatic cancer (52)
Parkinson's disease (103)
Partnered (16)
Patents (120)
Patient recruitment (71)
Peanut (26)
People (32171)
Pharmaceutical (20)
Pharmacy benefit managers (4)
Phase I (11926)
Phase II (16131)
Phase III (12705)
Pipeline (911)
Policy (77)
Postmarket research (1813)
Preclinical (6703)
Press Release (65)
Prostate cancer (68)
Psychedelics (20)
Radiopharmaceuticals (159)
Rare diseases (199)
Real estate (3673)
Recruiting (35)
Regulatory (10566)
Reports (28)
Research institute (2503)
Resumes & cover letters (186)
Rett syndrome (1)
RNA editing (1)
RSV (20)
Schizophrenia (51)
Series A (69)
Series B (35)
Service/supplier (10)
Sickle cell disease (35)
Special edition (12)
Spinal muscular atrophy (103)
Sponsored (22)
Startups (2123)
Stomach cancer (3)
Supply chain (27)
Tariffs (17)
The Weekly (12)
Vaccines (468)
Venture capitalists (13)
Weight loss (77)
Women's health (15)
Worklife (8)
Date
Today (95)
Last 7 days (528)
Last 30 days (1498)
Last 365 days (18949)
2025 (6118)
2024 (20271)
2023 (23561)
2022 (33054)
2021 (34767)
2020 (31728)
2019 (25941)
2018 (19462)
2017 (18646)
2016 (18608)
2015 (22118)
2014 (16667)
2013 (14788)
2012 (14724)
2011 (15391)
2010 (14279)
Location
Africa (536)
Alabama (44)
Alaska (3)
Arizona (85)
Arkansas (4)
Asia (24242)
Australia (4651)
California (3305)
Canada (1195)
China (315)
Colorado (134)
Connecticut (159)
Delaware (76)
Europe (57518)
Florida (539)
Georgia (116)
Idaho (21)
Illinois (276)
India (23)
Indiana (187)
Iowa (7)
Japan (124)
Kansas (44)
Kentucky (11)
Louisiana (4)
Maine (18)
Maryland (488)
Massachusetts (2421)
Michigan (138)
Minnesota (158)
Mississippi (1)
Missouri (48)
Montana (16)
Nebraska (10)
Nevada (25)
New Hampshire (23)
New Jersey (1092)
New Mexico (26)
New York (1124)
North Carolina (619)
North Dakota (5)
Northern California (1458)
Ohio (120)
Oklahoma (6)
Oregon (14)
Pennsylvania (698)
Puerto Rico (3)
Rhode Island (18)
South America (587)
South Carolina (12)
Southern California (1281)
Tennessee (41)
Texas (515)
United States (12847)
Utah (87)
Virginia (90)
Washington D.C. (45)
Washington State (365)
West Virginia (1)
Wisconsin (33)
393,656 Results for "prometheus research".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Entrada Cuts 20% of Workforce, Targeting Research Employees
Entrada is paring back its research staff even as it gears up to hire employees to support a planned clinical trial for a Duchenne muscular dystrophy candidate.
April 30, 2025
·
1 min read
·
Angela Gabriel
Biotech Beach
Prometheus Laboratories Announces New Health Plan Agreements to Provide Precision-Guided Testing Services
Prometheus Laboratories Inc. announced the execution of provider agreements with three large regional health plans to facilitate access to PredictrPK®, precision-guided biologic testing, and other Prometheus testing services to the participating health plans and their respective members.
May 9, 2024
·
2 min read
Press Releases
Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax
November 14, 2024
·
6 min read
Press Releases
American Academy of Dermatology Awards Podium Presentation to Phio Pharmaceutical’s Clinical Research at 2025 Annual Meeting
Interim Results from clinical study for cutaneous carcinomas presented at Late-Breaking Research Session
March 10, 2025
·
5 min read
Press Releases
Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology
U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology
March 5, 2025
·
2 min read
Drug Development
Site Survival: Why Clinical Research Sites Need a Lifeline
Elisa Cascade, CPO at Advarra explains why addressing the challenges faced by clinical research sites is vital for improving patient trust and the overall viability of clinical trials.
February 19, 2025
·
1 min read
·
Lori Ellis
Press Releases
Genprex Announces Research Collaborators’ Abstract Published in Cancer Research Supplement Proceedings
April 22, 2025
·
8 min read
Press Releases
Lupus Research Alliance Grants Lupus Innovation Awards to Eleven Talented Researchers to Accelerate Pace of Discovery in Lupus Research
April 16, 2025
·
7 min read
Deals
Merck Completes Acquisition of Prometheus Biosciences, Inc.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the Prometheus Biosciences, Inc. (“Prometheus”) (NASDAQ: RXDX) acquisition.
June 16, 2023
·
6 min read
Press Releases
City of Hope Scientists Present Leading-Edge Research at American Association for Cancer Research (AACR) Annual Meeting
April 25, 2025
·
15 min read
1 of 39,366
Next
